Patents by Inventor Steven Stone
Steven Stone has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20160141847Abstract: A remote tool device for remotely operating a tool and may include an isolation pole for insulating the remote tool device from the user, a pair of opposing contacts to make an electrical contact in a first position and a second position and a housing to house the contacts. The remote tool device may include a pivoting device to pivot between the first position and the second position.Type: ApplicationFiled: November 15, 2014Publication date: May 19, 2016Inventors: Kenny Kenny, Steven Stone
-
Publication number: 20150247208Abstract: Biomarkers and methods using the biomarkers for classifying cancer in a patient (e.g., predicting the risk of cancer-specific death or cancer recurrence) are provided.Type: ApplicationFiled: May 15, 2015Publication date: September 3, 2015Inventors: Steven Stone, Alexander Gutin, Susanne Wagner, Julia Reid
-
Publication number: 20150232947Abstract: Biomarkers and methods using the biomarkers for the prediction of the recurrence risk of cancer in a patient are provided.Type: ApplicationFiled: February 26, 2015Publication date: August 20, 2015Inventors: Steven Stone, Alexander Gutin, Susanne Wagner, Julia Reid
-
Publication number: 20150167103Abstract: Biomarkers and methods using the biomarkers for the prediction of the recurrence risk of cancer in a patient are provided.Type: ApplicationFiled: February 26, 2015Publication date: June 18, 2015Inventors: Steven Stone, Alexander Gutin, Susanne Wagner, Julia E. Reid
-
Publication number: 20140315935Abstract: The invention provides for molecular classification of disease and, particularly, molecular markers for lung cancer prognosis and therapy selection and methods and systems of use thereof.Type: ApplicationFiled: February 21, 2014Publication date: October 23, 2014Inventors: Susanne Wagner, Steven Stone, Alexander Gutin, Julia Reid
-
Publication number: 20140170242Abstract: The invention provides for molecular classification of disease and, particularly, molecular markers for lung cancer prognosis and therapy selection and methods and systems of use thereof.Type: ApplicationFiled: February 19, 2014Publication date: June 19, 2014Inventors: Susanne Wagner, Steven Stone, Alexander Gutin, Julia Reid
-
Publication number: 20130302242Abstract: Biomarkers and methods using the biomarkers for molecular detection and classification of disease and, particularly, molecular markers for cancer diagnosis and prognosis and methods of use thereof are provided.Type: ApplicationFiled: August 30, 2011Publication date: November 14, 2013Applicant: MYRIAD GENETICS, INC.Inventors: Steven Stone, Alexander Gutin, Susanne Wagner, Julia Reid
-
Publication number: 20130005592Abstract: The invention generally relates to molecular diagnostics, and particularly to molecular markers for cancer therapy response and methods of use thereof.Type: ApplicationFiled: September 10, 2010Publication date: January 3, 2013Applicants: Board of Regents of the University of Texas System, Myriad Genetics IncorporatedInventors: Steven Stone, Alexander Gutin, Darl Flake, Francisco J. Esteva, Dihua Yu
-
Publication number: 20120053253Abstract: Biomarkers and methods using the biomarkers for the prediction of the recurrence risk of cancer in a patient are provided.Type: ApplicationFiled: July 7, 2011Publication date: March 1, 2012Applicant: Myriad Genetics, IncorporatedInventors: Steven Stone, Alexander Gutin, Susanne Wagner, Julia Reid
-
Publication number: 20120041274Abstract: Biomarkers and methods using the biomarkers for the prediction of the recurrence risk of cancer in a patient are provided.Type: ApplicationFiled: July 7, 2011Publication date: February 16, 2012Applicant: Myriad Genetics, IncorporatedInventors: Steven Stone, Alexander Gutin, Susanne Wagner, Julia Reid
-
Patent number: 8034564Abstract: The present invention relates generally to the field of human genetics. Specifically, the present invention relates to methods and materials used to isolate and detect a human obesity and diabetes predisposing gene, specifically the TBC1D1 gene, some mutant alleles of which cause susceptibility to obesity and/or diabetes. More specifically, the invention relates to germline mutations in the TBC1D1 gene and their use in the diagnosis of predisposition to obesity and diabetes. Finally, the invention relates to the screening of the TBC1D1 gene for mutations/alterations, which are useful for diagnosing the predisposition to obesity.Type: GrantFiled: April 26, 2007Date of Patent: October 11, 2011Assignee: University of Utah Research FoundationInventors: Donna M. Shattuck, Steven Stone, Deanna L. Russell, Victor Abkevich, Steven Hunt
-
Publication number: 20110235311Abstract: An apparatus and method of protecting a pedestrian or cyclist from accidental collision with a vehicle wherein a first strip is directly or indirectly mounted on the rear of a user; the first strip including a plurality of light emitting devices that emit red light upon activation by a power means; and a second strip that is directly or indirectly mounted on the front of a user; the second strip including a plurality of light emitting devices that emit white, near white light upon activation by a power means; the first and second strips preferably forming an integral part of a garment worn by the user.Type: ApplicationFiled: March 25, 2010Publication date: September 29, 2011Applicant: LEDwear LimitedInventor: Steven STONE
-
Publication number: 20080085516Abstract: The present invention relates generally to the field of human genetics. Specifically, the present invention relates to methods and materials used to isolate and detect a human obesity and diabetes predisposing gene, specifically the TBC1D1 gene, some mutant alleles of which cause susceptibility to obesity and/or diabetes. More specifically, the invention relates to germline mutations in the TBC1D1 gene and their use in the diagnosis of predisposition to obesity and diabetes. Finally, the invention relates to the screening of the TBC1D1 gene for mutations/alterations, which are useful for diagnosing the predisposition to obesity.Type: ApplicationFiled: April 26, 2007Publication date: April 10, 2008Applicants: Myriad Genetics, Incorporated, University of Utah Research FoundationInventors: Donna Shattuck, Steven Stone, Deanna Russell, Victor Abkevich, Steven Hunt
-
Patent number: 7314713Abstract: The present invention relates generally to the field of human genetics. Specifically, the present invention relates to methods and materials used to isolate and detect a human obesity and diabetes predisposing gene, specifically the TBC1D1 gene, some mutant alleles of which cause susceptibility to obesity and/or diabetes. More specifically, the invention relates to germline mutations in the TBC1D1 gene and their use in the diagnosis of predisposition to obesity and diabetes. Finally, the invention relates to the screening of the TBC1D1 gene for mutations/alterations, which are useful for diagnosing the predisposition to obesity.Type: GrantFiled: September 3, 2003Date of Patent: January 1, 2008Assignees: Myriad Genetics, Inc., University of UtahInventors: Donna M. Shattuck, Steven Stone, Deanna L. Russell, Victor Abkevich, Steven Hunt
-
Publication number: 20070033707Abstract: An improved self adjusting cap for all weather use is disclosed. The improvement lies in the modified attached ear protecting band. The band has an upper edge attached to the crown and a shorter lower edge generally parallel to the upper edge. The lower edge has a shorter linear length than the upper edge so the band more closely conforms to the head of the wearer. Also, the band conforms to the head of the wearer when folded up into the cap without any bunching of material. Additionally, the two forward edges running from the upper edge to the lower edge have an arcuate shape which allows more of the face of the wearer to be protected without obstructing the peripheral vision of the wearer.Type: ApplicationFiled: August 11, 2005Publication date: February 15, 2007Inventor: Steven Stone
-
Publication number: 20050203809Abstract: The present invention provides a system that facilitates the selection of purchasable items for use in an environs defined by the customer. In one aspect, the system includes a processing element capable of proposing a plurality of purchasable items to the customer for selection by the customer. The processing element also is capable of receiving data representing the environs and data representing at least one purchasable item selected by the customer. The processing element is further capable of generating and displaying a three-dimensional graphical representation of the environs and each purchasable item or items selected by the customer so that the customer can visualize the items in the environs.Type: ApplicationFiled: March 9, 2004Publication date: September 15, 2005Inventors: Steven Stone, Santosh Bhasker, Alex Panzano, John Mitchell
-
Patent number: 6210949Abstract: The present invention relates to the Multiple Tumor Suppressor (MTS) genes in mice, their expression products, and their homology to the human MTS genes. The human MTS genes are involved in human cancers. The invention is further related to the use of the MTS genes in the therapy, diagnosis and prognosis of human cancer. The invention further relates to mutations in the MTS gene and their use in the diagnosis of predisposition to melanoma, leukemia, astrocytoma, glioblastoma, lymphoma, glioma, Hodgkin's lymphoma, CLL, and cancers of the pancreas, breast, thyroid, ovary, uterus, testis, kidney, stomach and rectum. The invention also relates to the therapy of human cancers which have a mutation in the MTS gene, including gene therapy, protein replacement therapy and protein mimetics. Finally, the invention relates to the screening of drugs for cancer therapy.Type: GrantFiled: November 30, 1998Date of Patent: April 3, 2001Assignee: Myriad Genetics, Inc.Inventors: Steven Stone, Ping Jiang, Alexander Kamb
-
Patent number: 5843756Abstract: The present invention relates to the Multiple Tumor Suppressor (MTS) genes in mice, their expression products, and their homology to the human MTS genes. The human MTS genes are involved in human cancers. The invention is further related to the use of the MTS genes in the therapy, diagnosis and prognosis of human cancer. The invention further relates to mutations in the MTS gene and their use in the diagnosis of predisposition to melanoma, leukemia, astrocytoma, glioblastoma, lymphoma, glioma, Hodgkin's lymphoma, CLL, and cancers of the pancreas, breast, thyroid, ovary, uterus, testis, kidney, stomach and rectum. The invention also relates to the therapy of human cancers which have a mutation in the MTS gene, including gene therapy, protein replacement therapy and protein mimetics. Finally, the invention relates to the screening of drugs for cancer therapy.Type: GrantFiled: July 28, 1995Date of Patent: December 1, 1998Assignee: Myriad Genetics, Inc.Inventors: Steven Stone, Ping Jiang, Alexander Kamb
-
Patent number: 5789206Abstract: The present invention is directed to cloning the ends of genes. Traditionally it has been very difficult to recover the 5' end of a gene. The present invention greatly eases this problem. The invention is a variation on RACE and uses a combination of techniques. Specific genes are purified by using three enrichment steps--1) a polymerase chain reaction, 2) a hybrid capture step, and 3) a second polymerase chain reaction. The inclusion of the hybrid capture step results in a greater enrichment than occurs with RACE. The ends of the gene are retained by use of a novel technique of attaching adaptors at the ends of the nucleic. The 5' end of the gene is conserved by preparing a first strand of cDNA and ligating to this an adaptor which is partially double stranded wherein the overhang or single stranded region of the adaptor is degenerate which allows for a fraction of the adaptor population to hybridize with the first strand of cDNA at the 3' end of the cDNA.Type: GrantFiled: July 7, 1995Date of Patent: August 4, 1998Assignee: Myriad Genetics, Inc.Inventors: Sean V. Tavtigian, Steven Stone, Ping Jiang, Alexander Kamb
-
Patent number: 4951413Abstract: A troll line depressor includes a pair of triangular wings with a dihedral angle of about 100 degrees therebetween. A rigid bridle connected between the upper and lower ends of the depressor provides a sliding connection for a ring at the end of a towing line, so that the depressor normally develops hydrodynanmic forces to depress the end of the towing line, but can tilt backward to an inoperative position when a fish strikes, or forward to an inoperative position if the depressor engages river bottom debris.Type: GrantFiled: May 24, 1989Date of Patent: August 28, 1990Inventors: Bruce D. Blevins, Steven Stone